Dr. Gregory Barton's research lab at UC Berkeley is focused on understanding how the immune system differentiates between self and non-self nucleic acids to prevent autoimmune diseases. His team studies Toll-like receptors (TLRs), especially TLR7 and TLR9, which are critical in regulating immune responses. They are exploring how specific proteins and external signals affect these receptors' functions, with the goal of developing better therapies for autoimmune conditions and enhancing tissue repair processes.

Dr. Gloria Ann Brar's lab focuses on understanding how cells rejuvenate their protein components during the formation of gametes, which are essential for sexual reproduction. By studying the simple budding yeast, they aim to identify the key proteins that are reset to maintain their youthfulness, even when derived from older cells. This research could provide insights into aging and new strategies to combat age-related cellular damage.

The Cate lab at UC Berkeley studies how protein synthesis, or translation, is regulated in humans. They focus on a special protein called eIF3 that controls how and when specific messenger RNAs are translated into proteins. This research is important because it can lead to new methods for treating diseases by better understanding translation control and developing new drugs targeting difficult-to-target proteins.

David G Drubin's lab at UC Berkeley focuses on understanding how cells take in materials and interact with their environment, particularly through a process called clathrin-mediated endocytosis (CME). They study this process in both yeast and human stem cells, using advanced imaging techniques to look at the proteins involved and how they function together. Their research aims to uncover the mechanisms behind how cells differentiate and respond under various conditions, which could have implications for understanding diseases and developing treatments.

Dr. Iswar K. Hariharan's lab at UC Berkeley focuses on understanding how growth is regulated in living organisms, particularly through studying the development and regeneration of structures in fruit flies (Drosophila). By examining the genetic mechanisms involved during both normal growth processes and regenerative growth after injury, the lab seeks to uncover the critical interactions between different cell types. This research is vital for gaining insights into various medical conditions, including cancer and birth defects, which are influenced by growth abnormalities.

Dr. Stephan Lammel's lab at UC Berkeley explores how certain brain systems influence behaviors related to reward and feeding. Using advanced techniques like optogenetics and fiber photometry, they investigate dopamine neurons and their role in learning and motivation. The lab's research has potential implications for treating disorders such as addiction and obesity by understanding how neural circuits operate in different contexts.

Dr. Roberto Zoncu’s lab at UC Berkeley focuses on how cells sense nutrients and signals through lysosomes, which are essential for cellular health and metabolism. They study the role of the mTORC1 protein in diseases like cancer and neurodegeneration, aiming to discover new therapeutic strategies. By exploring how cholesterol interacts with lysosomes, the lab aims to uncover mechanisms leading to kidney cancer and neurodegeneration, particularly in conditions like Niemann-Pick type C disease.

Dr. Na Ji's lab at UC Berkeley focuses on advancing optical imaging techniques to monitor neuronal activity with unprecedented speed and resolution. They are working on optimizing a technology called FACED, which will enhance the capability of two-photon microscopy to examine large areas of the brain at high frame rates. Their research aims to make these advanced imaging methods more accessible for various biological studies, ultimately contributing to our understanding of brain function and neural signaling.

Molly Ohainle's lab focuses on understanding how human cells defend against HIV and related viruses from primates. They investigate the molecular mechanisms by which certain host genes can restrict the infection of these viruses. The research aims to identify and manipulate host factors that limit HIV replication, which could lead to new treatments or even a cure for HIV infection.

Dr. Daniel Portnoy's lab at UC Berkeley studies how certain bacteria, like Listeria and Mycobacterium tuberculosis, evade our immune systems. They focus on understanding both the bacteria's tricks to cause disease and the body's responses to them. This research aims to develop better vaccines and treatments for bacterial infections by leveraging insights into the interactions between bacteria and immune responses.

Dr. Kathleen Collins' research lab at UC Berkeley focuses on understanding how certain enzymes, called non-LTR retrotransposons, insert DNA sequences into genomes. By studying the structure and function of these enzymes, her team aims to develop new methods for safely delivering transgenes into human cells, which could help treat genetic diseases. They use innovative techniques in biochemistry and molecular biology to explore the unique properties of these retrotransposons and their potential therapeutic applications.

Matthew D Welch's lab at UC Berkeley focuses on understanding how the Rickettsia bacteria invade host cells and survive within them. They explore the molecular mechanisms that allow these pathogens to escape immune responses and move within cells. This research is not only crucial for creating effective diagnostics and treatments for diseases caused by Rickettsia but also enhances our overall understanding of host-pathogen interactions.

Dr. Hei Sook Sul's lab at UC Berkeley is focused on understanding how certain genes are activated in brown fat cells to help regulate body temperature and energy expenditure. The team studies a specific protein called UCP1, which plays a crucial role in burning fat to produce heat. By exploring how the activity of UCP1 is regulated, the lab aims to uncover new strategies for treating obesity and related metabolic diseases like diabetes.

David Bilder's lab at UC Berkeley focuses on understanding the biology of epithelial tissues, which are essential for forming protective barriers in animals. The lab uses fruit flies, Drosophila, to study how these tissues develop their shapes and how they respond to injuries. This research aims to uncover important mechanisms that can help repair damaged organs and prevent congenital defects.

Hillel Adesnik's lab at UC Berkeley focuses on understanding how neural circuits in the primary visual cortex process visual information. They study how excitatory and inhibitory neurons interact to help us perceive our surroundings, particularly looking at phenomena like figure/ground segregation. The work involves advanced imaging and optogenetics to explore the detailed architecture and functioning of these circuits.

Dr. Lin He's lab at UC Berkeley studies the role of retrotransposons—genetic elements that can move around within the genome—in mammalian development and reproductive aging. Their research aims to uncover how these elements influence gene regulation during early embryo development and the aging process of female reproductive cells. By using advanced techniques like CRISPR and genomics, the lab investigates the functional significance of retrotransposon-derived promoters and how they can lead to alternative gene forms that impact cell functions.

Dr. Donald C. Rio's lab at UC Berkeley focuses on understanding DNA transposons and their roles in gene expression, especially through a process called alternative pre-mRNA splicing. Their research explores how these mobile genetic elements impact human health and development, including their contributions to diseases like ALS. By studying these processes in model organisms like Drosophila and through advanced techniques like cryo-electron microscopy, the lab aims to uncover critical insights into gene regulation that could lead to biomedical advancements.

Dr. Sarah A. Stanley's lab focuses on understanding how the bacteria Mycobacterium tuberculosis (Mtb) suppresses the human immune system, which allows for chronic infections. The lab investigates two key components, the ESX-1 secretion system and a lipid called PDIM, to see how they work together to evade the immune response. By studying these mechanisms in mouse models, the lab aims to uncover new potential therapies to combat tuberculosis, one of the deadliest infectious diseases.

Dr. Michel Dupage's lab focuses on understanding how regulatory T cells (Tregs) hinder the effectiveness of cancer immunotherapies. By studying the mechanisms through which Tregs suppress the immune response within tumors, the lab aims to develop targeted therapies that can enhance anti-tumor immunity while minimizing autoimmune side effects. This research is crucial for improving cancer treatment options and making immunotherapies more effective for patients.

Dr. Russell E. Vance's lab at UC Berkeley focuses on understanding how the bacteria Shigella causes disease. By developing a new mouse model that mimics human infection, the lab investigates the immune response and key cellular players that contribute to disease severity and resolution. Their research has significant implications for public health, particularly in combatting diarrheal diseases that affect millions worldwide.